[ad_1]
The inventory quoted a 52-week excessive value of Rs 1063.75 and low of Rs 620.55.
As of 12:49PM (IST), the counter noticed whole traded quantity of 37,117 shares with a traded worth of Rs 2.47 crore, in keeping with NSE.
The inventory had closed at Rs 670.6 within the earlier session.
The scrip has declined -4.11 per cent previously one month until date, whereas the benchmark BSE Sensex has slipped -0.02 per cent throughout the identical interval.
In response to alternate information, the inventory traded at a price-to-earnings (P/E) a number of of seven.48 whereas price-to-book ratio stood at 2.36. The next P/E ratio exhibits that traders are prepared to pay a better value for per rupee earnings given by the inventory due to higher future development expectations. The value-to-book worth signifies the inherent worth of an organization and it displays the value traders are able to pay even for no development in a enterprise.
The inventory belongs to the Pharma – Indian business.
Promoter/FII Holding
Promoters held 48.76 per cent stake within the firm as of 31-Dec-2021, whereas FII and MF possession within the agency stood at 21.37 per cent and 9.56 per cent, respectively.
Key Financials
The corporate reported consolidated gross sales of Rs 6038.5 crore for the quarter ended 30-Sep-2021, up 4.41 per cent from the earlier quarter’s Rs 5783.29 crore and up 7.63 per cent from the year-ago quarter’s Rs 6537.19 crore. Its web revenue for the most recent quarter stood at Rs 696.99 crore, down 13.55 per cent from the identical quarter a 12 months in the past.
[ad_2]
Source link
